Neglected Cardiovascular Diseases in Africa. Challenges and Opportunities

Journal of the American College of Cardiology

Volumn 55, Issue 7, 2010, Pages 680-687

  Mocumbi, Ana Olga H ^a   Ferreira, Maria Beatriz ^a  

^a Instituto do Coracao Maputo   (Mozambique)

Author keywords

Africa; cardiovascular diseases; neglected

Indexed keywords

CYTOTOXIC AGENT; IMMUNOSUPPRESSIVE AGENT; STEROID;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; AORTA ARCH SYNDROME; BURKITT LYMPHOMA; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; COMORBIDITY; ECHOCARDIOGRAPHY; EDITORIAL; EPIDEMIC; GEOGRAPHIC DISTRIBUTION; HEALTH CARE QUALITY; HEART CATHETERIZATION; HEART LEFT VENTRICLE ANEURYSM; HEART MUSCLE FIBROSIS; HEART VALVE SURGERY; HOSPITAL PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPH NODE IRRADIATION; MORBIDITY; PREVALENCE; PRIORITY JOURNAL; RHEUMATIC HEART DISEASE; SCHISTOSOMIASIS; SURVIVAL RATE; TUBERCULOUS PERICARDITIS;

AFRICA; BURKITT LYMPHOMA; CARDIOVASCULAR DISEASES; COMMUNICABLE DISEASES; CULTURE; FEMALE; HEALTH EDUCATION; HEALTH PRIORITIES; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; MALNUTRITION; POLICY MAKING; POVERTY; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; RESEARCH SUPPORT AS TOPIC;

EID: 76649105142     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.09.041     Document Type: Editorial

References (69)

1. Anthony K.K. Pattern of cardiac failure in Northern savanna Nigeria. Trop Geogr Med 32 (1980) 118-125
2. Ansa V.O., Ekott J.U., and Bassev E.O. Profile and outcome of cardiovascular admissions at the University of Uyo Teaching Hospital, Uyo-a five-year review. Niger J Clin Pract 11 (2008) 22-24
3. Hodes R.M. Pattern of heart disease in Ethiopia as seen in cardiology referral clinic. Cardiology 75 (1988) 458-464
4. Freers J., Mayanja-Kizza H., Ziegler J.J., and Rutakingirwa M. Echocardiographic diagnosis of heart disease in Uganda. Trop Doct 26 (1996) 125-128
5. Soliman E.Z., and Juma H. Cardiac disease patterns in Northern Malawi: epidemiologic transition perspective. J Epidemiol 18 (2008) 204-208
6. Sliwa K., Wilkinson D., Hansen C., et al. Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study. Lancet 371 (2008) 915-922
7. Marijon E., Phalla O., Celermajer D.S., et al. Prevalence of rheumatic heart disease by echocardiographic screening. N Engl J Med 357 (2007) 470-476
8. Longo-Mbenza B., Nayekula M., Ngilulu R., et al. Survey of rheumatic heart disease in school children of Kinshasa Town. Int J Cardiol 63 (1998) 287-294
9. Mocumbi A.O., Ferreira M.B., Sidi D., and Yacoub M.H. A population study of endomyocardial fibrosis in a rural area of Mozambique. N Engl J Med 369 (2008) 43-49
10. WHO Report of the Regional Committee of Africa 2005. http://www.afro.who.int/rc55/documents/afr_rc55_12_cardiovascular.pdf Accessed December 31, 2009
11. WHO. 1980 community control of RHD in developing countries: a major public health problem. World Health Organ Chron 34 (1980) 336-345
12. Essop M.E., and Nkomo V.T. Rheumatic and nonrheumatic valvular heart disease: epidemiology, management and prevention in Africa. Circulation 112 (2005) 3584-3591
13. Marcus R.H., Sareli P., Pocock W.A., and Barlow J.B. The spectrum of severe rheumatic mitral valve disease in a developing country: correlations among clinical presentation, surgical pathologic findings and hemodynamic sequelae. Ann Int Med 120 (1994) 177-183
14. Stanfield J.P., and Bracken P.M. Antistreptolysin O titers in the childhood population in rural and semi rural Buganda. East Afr Med J 50 (1973) 153-157
15. Rotta J., Jehnek J., Zacek K., de Vries J.L., Chanthravetra P., and Antal G.M. Antistreptolysin O surveys as an indicators of the prevalence of streptococcal infection among the populations of Thailand, Pakistan and E. Nigeria. WHO Surveillance Reports CES/SR/66.4 (1966), World Health Organization, Geneva
16. Dunbar J.M., and Erwa H. Antistreptolysin O titers in school children in Khartoum. Bull World Health Organ 37 (1967) 492-495
17. Duran C.M., Gometza B.H., and Saad E. Valve repair in rheumatic mitral disease: an unsolved problem. J Cardiol Surg 9 (1994) 282-285
18. Gometza B.H., al-Halees Z., Shahid M., Hatle L.K., and Duran C.M. Surgery for rheumatic mitral regurgitation in patients below twenty years of age. An analysis of failures. J Heart Valve Dis 5 (1996) 294-301
19. Yau T.M., El-Ghoneimi Y.A.F., Armstrong S., Ivanov J., and David T.E. Mitral valve repair and replacement for rheumatic disease. J Thorac Cardiovasc Surg 119 (2000) 53-61
20. Bernal J.M., Rabassa J.M., Vilchez F.G., Cagigas J.C., and Revuelta J.M. Mitral valve repair in rheumatic disease: the flexible solution. Circulation 88 (1993) 1746-1753 Part 1
21. Zaher S.R., and Mandil A. Practical problems associated with the prevention of initial and recurrent attacks of acute rheumatic fever in developing countries. Issues Infect Dis Basel Krager 3 (2004) 173-183
22. Somers K. Restrictive cardiomyopathies. In: Pongpanich B., Sueblinvong V., and Vongprateep C. (Eds). Pediatric Cardiology. International Congress Series 906 (1990), Excerpta Medica, Amsterdam
23. Mayanga-Kizza H., Gerwing E., Rutakingirwa M., Mugerwa R., and Freers J. Tropical endomyocardial fibrosis in Uganda: the tribal and geographic distribution, and the association with eosinophilia. Trop Cardiol 26 (2000) 45-48
24. Rutakingirwa M., Ziegler J.L., Newton R., and Freers J. Poverty and eosinophilia are risk factors endomyocardial fibrosis (EMF) in Uganda. Trop Med Inter Health 4 (1999) 229-235
25. Andy J.J., Ogunowo P.O., Akpan N.A., Odigwe C.O., Ekanem I.A., and Esin R.A. Helminth associated hypereosinophilia and tropical endomyocardial fibrosis (EMF) in Nigeria. Acta Tropica 69 (1998) 127-140
26. Shaper A.G., Kaplan M.H., Mody N.J., and McIntyre P.A. Malarial antibodies and autoantibodies to heart and other tissues in the immigrant and indigenous peoples of Uganda. Lancet 291 (1968) 1342-1347
27. Victor E.G., Lira V., Arruda A., Monteiro I., and Lima R. Granulomas cardiacos a ovos de schistosoma e fibrose endomiocardica [Cardiac granulomas due to schistosoma eggs and endomyocardial fibrosis]. Arq Bras Cardiol 67 (1996) 259-261
28. Berenguer A., Plancha E., and Gil J.M. Right ventricular endomyocardial fibrosis and microfilarial infection. Int J Cardiol 87 (2003) 287-289
29. Ijaola O., and Falase A.O. Distribution of antibodies against Coxsackie B viruses, arboviruses and Toxoplasma gondii among patients with endomyocardial fibrosis (EMF) compared with normal subjects from EMF endemic and non-endemic zones of Nigeria. Afr J Med Sci 19 (1990) 93-103
30. Mathai A., Kartha C.C., and Balakrishnan K.G. Serum immunoglobulins in patients with endomyocardial fibrosis. Indian Heart J 38 (1986) 470-472
31. Patel A.K., Ziegler J.L., D'Arbela P.G., and Somers K. Familial cases of endomyocardial fibrosis in Uganda. Br Med J 4 (1971) 331-334
32. Lowenthal M.N. Endomyocardial fibrosis: familial and other cases from Zambia. Med J Zambia 12 (1978) 2-7
33. Patel A.K., D'Arbela P.G., and Somers K. Endomyocardial fibrosis and eosinophilia. Br Heart J 39 (1977) 238-241
34. Urhoghide G.E., and Falase A.O. Degranulated eosinophils, eosinophil granule basic proteins and humoral factors in Nigerians with endomyocardial fibrosis. Afr J Med Sci 16 (1987) 133-139
35. Somers K., Hutt M.S.R., Patel A.K., and D'Arbela P.G. Endomyocardial biopsy in diagnosis of cardiomyopathies. Br Heart J 33 (1971) 822-832
36. Connor D.H., Somers K., Hutt N.S.R., Manion W.C., and D'Arbela P. Endomyocardial fibrosis in Uganda (Davies' disease). Part II. Am Heart J 74 (1968) 107-124
37. Jaiyesimi F., and Falase A.O. Extracardiac manifestations of endomyocardial fibrosis and their psychosocial complications. Trop Cardiol 2 (1976) 5-11
38. Bolarin D.M., and Andy J. Clinical feminization and serum testosterone levels in male patients with chronic African endomyocardial fibrosis. Trop Geogr Med 34 (1982) 309-312
39. Mocumbi A.O., Sidi D., Vouhe P., and Yacoub M. An innovative technique for the relief of right ventricular trabecular cavity obliteration in endomyocardial fibrosis. J Thorac Cardiovasc Surg 134 (2007) 1070-1072
40. Desai D., Moodley J., and Naidoo D. Peripartum cardiomyopathy: experience at King Edward Hospital, Durban, South Africa and a review of literature. Trop Doct 25 (1995) 118-123
41. Isezuo S.A., and Abubakar S.A. Epidemiologic profile of peripartum cardiomyopathy in a tertiary care hospital. Ethn Dis 17 (2007) 228-233
42. Ford L., Abdullahi A., Anjorin F.I., et al. The outcome of peripartum cardiac failure in Zaria, Nigeria. QJM 91 (1998) 93-103
43. Hilfiker-Kleiner D., Kaminsky K., Podewski E., et al. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 128 (2007) 589-600
44. Hilfiker-Kleiner D., Sliwa K., and Drexler H. Peripartum cardiomyopathy: recent insights in its pathophysiology. Trends Cardiovac Med 18 (2008) 173-179
45. Mayosi B.M., Burgess L.J., and Doubell A.F. Tuberculous pericarditis. Circulation 112 (2005) 3608-3616
46. Cegielski J.P., Ramiya K., Lallinger G.J., Mtulia I.A., and Mbaga I.M. Pericardial disease and human immunodeficiency virus in Dar es Salaam, Tanzania. Lancet 335 (1990) 209-212
47. Mayosi B.M., Volmink J.A., and Commerford P.J. Pericardial disease: an evidence based approach to diagnosis and treatment. In: Yusuf S., Cairns J.A., Camm A.J., Fallen E.L., and Gersh B.J. (Eds). Evidence Based Cardiology. 2nd edition (2002), BMJ Books, London, U.K
48. Mayosi B., Wiysonge C.S., Ntsekhe M., et al. Mortality in patients treated for tuberculous pericarditis in sub-Saharan Africa. S Afr Med J 98 (2008) 36-40
49. Doumenge J.P., Mott K.E., Cheung C., et al. [Atlas of the Global Distribution of Schistosomiasis.] Talence, CEGET-CNRS (1987), World Health Organization, Geneva 400
50. Morris W., and Knauer C.M. Cardiopulmonary manifestations of schistosomiasis. Semin Respir Infect 12 (1997) 159-170
51. 10, 3-1988, 14p.
52. McCulloch M., Andronikon S., Goddard E., et al. Angiographic features of 26 children with Takayasu's arteritis. Pediatr Radiol 33 (2003) 210-235
53. Reddy E., and Robbs J.V. Surgical management of Takayasu's arteritis in children and adolescents. Cardiovasc J Afr 18 (2007) 393-396
54. Mwipatayi B.P., Jeffery P.C., Beningfield S.J., et al. Takayasu arteritis: clinical features and management: report of 272 cases. ANZ J Surg 75 (2005) 110-117
55. Hahn D., Thomson P.D., Kala U., Beale P.G., and Levin S.E. A review of Takayasu's arteritis in children in Gauteng, South Africa. Pediatr Nephrol 12 (1998) 668-675
56. Chesler E., Mitha A.S., and Edwards J.E. Congenital aneurysms adjacent to the annuli of the aortic and/or mitral valves. Chest 82 (1982) 334-337
57. Kontozis L., Skoularigis J., Skudicky D., and Sareli P. Submitral aneurysm. Circulation 98 (1998) 1698
58. Abrahams D.G., Barton C.J., Cockshot W.P., Edington G.M., and Weaver E.J.M. Annular subvalvular left ventricular aneurysms. Q J Med 31 (1962) 345-360
59. Ojesina A.I., Akang E.E., and Ojemakinde K.O. Decline in frequency of Burkitt's lymphoma relative to other childhood malignancies in Ibadan, Nigeria. Ann Trop Paediatr 22 (2002) 159-163
60. Ahmad S., and Molyneux E. Intra-cardiac Burkitt's lymphoma. Arch Dis Child 90 (2005) 237
61. Orem J., Mbidde E.K., Lambert B., Sanjose S., and Weiderpass E. Burkitt's lymphoma in Africa, a review of the epidemiology and etiology. Afr Health Sci 7 (2007) 166-175
62. Imai S., Sugiura M., Mizuno F., et al. African Burkitt's lymphoma: a plant, Euphorbia tirucalli, reduces Epstein-Barr virus-specific cellular immunity. Anticancer Res 14 (1994) 933-936
63. Geser A., Brubaker G., and Draper C.C. Effect of malaria suppression program on incidence of African Burkitt's lymphoma. Am J Epidemiol 129 (1989) 740-752
64. Kadiri S. Tackling cardiovascular diseases in Africa. BMJ 331 (2006) 711-712
65. United Nations World Population Prospects: 2006 revision-Table A.18 and A.19 [Internet]. http://www.un.org/esa/population/publications/wpp2006/ WPP2006_Highlights_rev.pdf Accessed December 21, 2007
66. Davidson M.H., and Parry E.H.O. Peripartum cardiac failure. In: Shaper A.G., Hutt M.S.R., and Feijar Z.B.M.A. (Eds). Cardiovascular Disease in the Tropics (1974), British Medical Association, London 199-208
67. Mayosi B., Robertson K., Volmink J., et al. The Drakensberg declaration on the control of rheumatic fever and rheumatic heart disease in Africa. S Afr Med J 96 (2006) 246
68. Yacoub S., Kotit S., Mocumbi A.O., and Yacoub M. Neglected diseases in cardiology: the need for urgent action. Nat Clin Pract Cardiovasc Med 5 (2008) 176-177
69. Troullier P., Olliaro P., Torreele E., Orbinski I., Laing R., et al. Drug development for neglected diseases: a deficient market and public heal policy failure. Lancet 359 (2002) 2188-2194